An 18-month-old in London, England, is one of the youngest children to receive gene therapy to treat hearing loss caused by a mutation in the OTOF gene. This gene produces a protein called Otoferlin that allows for communication between cells of the cochlea and the brain.
The recipient received an infusion of a functional copy of the OTOF in her ear. The procedure was completed in just 16 minutes. Reportedly, it only took a few weeks for the child to begin to hear and respond to sounds without the help of her cochlear implant.
References
Afzali K. (2024) Toddler born deaf can hear after gene therapy trial breakthrough her parents call “mind-blowing.”CBS News(accessed May 13, 2024).
Related Posts
Echoes of Risk: Noise-Induced Hearing Loss in Dentistry
For audiologists, it is no surprise that dental professionals remain at risk of developing noise-induced hearing loss (NIHL). This risk is due to prolonged and…
The Hobbies Most Likely to Cause Hearing Loss
Hobbies are important. They contribute to our overall health and well-being by helping us relax and escape everyday stressors. Audiologists know that some hobbies may…
NCAA Approves Gallaudet’s Use of a Helmet for Deaf or Hard of Hearing Players This Season
A helmet designed by Gallaudet University and AT&T has been approved for use by the NCAA. Approval for the helmet in Division III college football…